Clinical Trial Update: Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing exemestane plus celecoxib versus exemestane plus placebo in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• CELEBREX (Celecoxib)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED